Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/08/26/2287410/0/en/Aadi-Bioscience-Announces-Closing-of-Merger-with-Aerpio-Pharmaceuticals-and-155M-Private-Placement.html
https://www.globenewswire.com/news-release/2021/05/19/2232928/0/en/Aerpio-Provides-Update-on-Aadi-Bioscience-Presentation-at-the-ASCO-2021-Virtual-Meeting.html#:~:text=(%E2%80%9CAerpio%E2%80%9D)%20(Nasdaq,the%20American%20Society%20of%20Clinical
https://www.globenewswire.com/news-release/2021/05/17/2230530/0/en/Aerpio-Pharmaceuticals-and-Aadi-Bioscience-Enter-into-a-Definitive-Merger-Agreement.html
https://www.biospace.com/article/releases/aerpio-pharmaceuticals-and-aadi-bioscience-enter-into-a-definitive-merger-agreement/?s=79
https://www.globenewswire.com/news-release/2021/01/05/2153803/0/en/Aerpio-Announces-Strategic-Review-after-Topline-Results-from-Razuprotafib-Glaucoma-Phase-2-Trial.html
https://www.globenewswire.com/news-release/2020/12/11/2144068/0/en/Aerpio-Announces-Statistically-Significant-Topline-Results-from-Razuprotafib-Glaucoma-Phase-2-Trial.html
https://www.globenewswire.com/news-release/2020/11/05/2121459/0/en/Aerpio-Hosting-Key-Opinion-Leader-Call-on-New-Therapeutic-Agents-for-COVID-19.html
https://www.globenewswire.com/news-release/2020/10/26/2114608/0/en/Aerpio-Announces-First-Patient-Dosed-with-Razuprotafib-in-the-Phase-2-Trial-for-the-Prevention-and-Treatment-of-ARDS-in-Patients-with-Moderate-to-Severe-COVID-19.html
https://www.prnewswire.com/news-releases/aerpio-and-quantum-leap-announce-first-patients-dosed-with-razuprotafib-in-the-i-spy-covid-trial-to-treat-ards-in-critically-ill-covid-19-patients-301122401.html
https://www.globenewswire.com/news-release/2020/08/04/2072868/0/en/Aerpio-Pharmaceuticals-Inc-Announces-a-Second-Clinical-Trial-with-Funding-from-MTEC-to-Evaluate-Razuprotafib-for-the-Prevention-and-Treatment-of-ARDS-in-Patients-with-Moderate-to-S.html